Cognito Therapeutics is partnering with a nonprofit to “Change the D-Word,” aiming to eliminate the use of “dementia,” a catchall term that can carry stigma. The term “dementia” is an umbrella term ...

New research shows that sourdough fermentation does more than make bread rise—it transforms wheat fibers in unexpected ways. Scientists found that enzymes already present in wheat, activated by the ...

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. This voice experience is generated by AI. Learn more. This ...

Cognito Therapeutics, a company using visual and auditory stimulation to treat neurodegenerative disorders, announced it closed an oversubscribed $105 million Series C funding round. Morningside ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Cognito Therapeutics has raised $105m to advance the clinical development and commercial preparedness for its Alzheimer’s disease therapeutic. The Massachusetts-based company’s oversubscribed Series C ...

Vicki Denig is a wine and travel journalist who divides her time between New York and Paris. She is a certified wine specialist who has worked in the wine trade since 2013. The techniques used to ...

A person's "bioenergetic age"—or how youthfully their cells generate energy—might be a key indicator of whether they're at risk of developing Alzheimer's disease, new research from Weill Cornell ...

Precision fermentation is fast becoming a key part of the world of food. More precise than traditional or biomass fermentation, it’s a tool through which to develop flavours, vitamins, plant-based ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--#alzheimers--Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced key ...

Amazon Web Services (AWS) has announced updates to Amazon Cognito, its identity and access management service for Web and mobile applications. The service allows developers to secure ...